LAVA Therapeutics's total assets for Q3 2025 were $51.91M, a decrease of -14.26% from the previous quarter. LVTX total liabilities were $39.23M for the fiscal quarter, a -3.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.